Doctor Alexander Tindale

Doctor Alexander Tindale

National Heart and Lung Institute Imperial College, London (United Kingdom of Great Britain & Northern Ireland)

Dr Tindale is a cardiology registrar based at Harefield Hospital and a doctoral student at the National Heart and Lung Institute, Imperial College London. His research focuses on the application of quantitative methods to the optimisation of haemodynamics in cardiac critical care, ranging from pacemaker optimisation to the identification and treatment of patients with cardiogenic shock. He studied Natural Sciences at the University of Cambridge (Emmanuel College) before taking his MBBS at Imperial College London. In addition, he has a degree in Business & Finance from the Judge Business School, University of Cambridge. Away from medicine, his research interests include improving his golf handicap and scoring more runs on the cricket field.

Presentations Articles

Validation of the BALLAR score for predicting 30-day mortality in patients requiring Impella monotherapy

Event: ESC Congress 2023

Topic: Shock

Session: Risk stratification in acute coronary syndromes with cardiogenic shock

Access

The BE-ALIVE score: predicting 30-day mortality in patients presenting with acute coronary syndromes and cardiogenic shock

Event: ESC Congress 2023

Topic: Shock

Session: Risk stratification in acute coronary syndromes with cardiogenic shock

Access

Lowest peak central venous pressure correlates with highest invasive arterial blood pressure as a method for optimising AV delay in post-surgical temporary pacing

Event: EHRA 2023

Topic: Antibradycardia Pacing

Session: ePoster session 51

Access

Creation and validation of a biochemical scoring system and smartphone application to predict 30 day mortality in patients requiring left-sided Impella monotherapy

Event: ESC Acute CardioVascular Care 2022

Topic: Cardiogenic Shock

Session: e-Posters session

Access

Doctor Alexander Tindale

Biography

Contributor content

Validation of the BALLAR score for predicting 30-day mortality in patients requiring Impella monotherapy

The BE-ALIVE score: predicting 30-day mortality in patients presenting with acute coronary syndromes and cardiogenic shock

Lowest peak central venous pressure correlates with highest invasive arterial blood pressure as a method for optimising AV delay in post-surgical temporary pacing

Creation and validation of a biochemical scoring system and smartphone application to predict 30 day mortality in patients requiring left-sided Impella monotherapy

ESC 365 is supported by